Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

[Research advance on transfusion-related immunomodulation].

Zhu XF, Xia R.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Feb;18(1):268-72. Review. Chinese.

PMID:
20137161
2.

Transfusion immunomodulation or TRIM: what does it mean clinically?

Blajchman MA.

Hematology. 2005;10 Suppl 1:208-14. Review.

PMID:
16188675
3.
4.

Transfusion-related immunomodulation (TRIM): an update.

Vamvakas EC, Blajchman MA.

Blood Rev. 2007 Nov;21(6):327-48. Epub 2007 Sep 4. Review.

PMID:
17804128
5.

Immunomodulation and blood transfusion.

Blajchman MA.

Am J Ther. 2002 Sep-Oct;9(5):389-95. Review.

PMID:
12237730
6.

[Transfusion-induced immunomodulation and infectious complications].

Bucová M, Mistrík M.

Vnitr Lek. 2006 Nov;52(11):1085-92. Review. Czech.

PMID:
17165529
7.

Transfusion-related immunomodulation by platelets is dependent on their expression of MHC Class I molecules and is independent of white cells.

Aslam R, Speck ER, Kim M, Freedman J, Semple JW.

Transfusion. 2008 Sep;48(9):1778-86. doi: 10.1111/j.1537-2995.2008.01791.x. Epub 2008 Jun 2.

PMID:
18522705
8.

Transfusion-transmissible infections and transfusion-related immunomodulation.

Buddeberg F, Schimmer BB, Spahn DR.

Best Pract Res Clin Anaesthesiol. 2008 Sep;22(3):503-17. Review.

9.

Transfusion-related immunomodulation due to peripheral blood dendritic cells expressing the CD200 tolerance signaling molecule and alloantigen.

Clark DA, Gorczynski RM, Blajchman MA.

Transfusion. 2008 May;48(5):814-21. doi: 10.1111/j.1537-2995.2008.01654.x. Epub 2008 Feb 21.

PMID:
18298594
10.

Transfusion immunomodulation from a clinical perspective: an update.

Refaai MA, Blumberg N.

Expert Rev Hematol. 2013 Dec;6(6):653-63. doi: 10.1586/17474086.2013.850026. Epub 2013 Oct 30. Review.

PMID:
24168641
11.
12.

Transfusion-associated immune modulation: a reason to TRIM platelet transfusions?

Geiger TL.

Transfusion. 2008 Sep;48(9):1772-3. doi: 10.1111/j.1537-2995.2008.01860.x. No abstract available.

PMID:
18811896
13.

Transfusions of blood products and cancer outcomes.

Velásquez JF, Cata JP.

Rev Esp Anestesiol Reanim. 2015 Oct;62(8):461-7. doi: 10.1016/j.redar.2015.02.013. Epub 2015 Apr 17.

PMID:
25896733
14.

Immunomodulatory effects of blood transfusions: the synergic role of soluble HLA Class I free heavy-chain molecules detectable in blood components.

Ghio M, Contini P, Ubezio G, Mazzei C, Puppo F, Indiveri F.

Transfusion. 2008 Aug;48(8):1591-7. doi: 10.1111/j.1537-2995.2008.01720.x. Epub 2008 May 6.

PMID:
18466172
16.
17.
18.

Possible mechanisms of allogeneic blood transfusion-associated postoperative infection.

Vamvakas EC.

Transfus Med Rev. 2002 Apr;16(2):144-60. Review.

PMID:
11941576
19.

Mechanisms of transfusion-associated immunosuppression.

Blajchman MA, Bordin JO.

Curr Opin Hematol. 1994 Nov;1(6):457-61. Review.

PMID:
9371323
20.

Allogeneic transfusion and infection: economic and clinical implications.

Blumberg N.

Semin Hematol. 1997 Jul;34(3 Suppl 2):34-40. Review.

PMID:
9253782

Supplemental Content

Support Center